Provigil (Modafinil) Cost in New York: Prices, Insurance, and Savings in 2026

Modafinil is a wakefulness-promoting agent, DEA Schedule IV, sold under the brand name Provigil (Cephalon/Teva) and as a generic tablet manufactured by several companies. The FDA-approved indications are narcolepsy, obstructive sleep apnea (as an adjunct to primary OSA therapy), and shift work disorder. Any use outside those indications is off-label.

Direct answer: Generic modafinil is far cheaper than brand-name Provigil at New York pharmacies because the drug lost patent exclusivity years ago and multiple generic manufacturers now compete. New York Medicaid and most commercial plans cover generic modafinil, generally with prior authorization tied to a documented FDA-approved indication, but exact copays, tier placement, and cash prices change often and vary by pharmacy, insurer, and plan year. Anyone relying on a specific dollar figure or coverage rule for a decision today should confirm it directly with the pharmacy or insurer rather than trusting a fixed number in an article.

That last point is the core tension on this page: the clinical facts about modafinil are stable and well documented, but almost everything about price and coverage in New York is time-sensitive and plan-specific. The rest of this article separates the two.

What Is Actually Stable: The Clinical and Regulatory Facts

• Modafinil is FDA-approved for narcolepsy, OSA (adjunct), and shift work disorder, and it carries FDA prescribing information on file.
• It is a Schedule IV controlled substance under federal law, which limits refills and requires electronic prescribing safeguards for controlled substances.
• Generic versions have been available in the United States for over a decade, and multiple manufacturers (Teva, Mylan, Sun Pharma, and others) currently supply the market. Brand Provigil's list price is substantially higher than the generic cash price at essentially every U.S. pharmacy, though the exact multiple changes with time and pharmacy.
• Randomized controlled trial evidence and systematic review evidence, including a Cochrane review of pharmacologic treatments for narcolepsy, support modafinil's efficacy for reducing excessive daytime sleepiness in narcolepsy. This body of evidence is the reason modafinil sits in guideline-recommended first-line pharmacologic options for narcolepsy-related sleepiness, though the exact effect sizes reported in individual trials should be checked against the primary paper before being quoted as a specific number, since specific trial statistics for this article could not be independently verified against a confirmed source and are not repeated here.
• New York permits 503A compounding of modafinil by properly licensed pharmacies, and permits telehealth prescribing of controlled substances under state law, subject to New York's electronic prescribing requirements for controlled substances.

These facts do not change month to month. What changes constantly is money: cash prices, insurer tiers, PA turnaround times, and discount card terms.

Brand vs. Generic Pricing in New York

Brand-name Provigil's manufacturer list price is high, commonly cited in the multiple hundreds of dollars per 30-day supply, but list price is not what most insured patients pay, and even self-pay patients rarely fill the brand version once a generic exists. Generic modafinil 200 mg tablets are widely reported to cost far less at retail pharmacies, with cash prices varying by pharmacy chain, region, and whether a discount card is applied.

This page previously stated a specific brand list price and a specific New York statewide generic average as if they were confirmed figures. Neither number could be verified against a primary pricing source for this draft, and cash and list prices for prescription drugs change frequently. Readers should treat any specific dollar figure for Provigil or generic modafinil, whether from this page or elsewhere, as a snapshot that needs confirmation at the pharmacy counter or through a current price-comparison tool (for example, a pharmacy's own quote, GoodRx, or a similar service) on the day of fill.

What is reasonably well established: generic modafinil in New York costs a small fraction of brand Provigil's list price, and 90-day fills, discount cards, and mail-order pharmacies (such as Mark Cuban Cost Plus Drug Company) are commonly cited as lower-cost channels. What is not established here: the exact current dollar amounts for any of these channels, since prices shift regularly and vary by location.

New York Medicaid Coverage

New York Medicaid generally requires prior authorization for modafinil, and prescribers typically need to document a qualifying diagnosis, most straightforwardly narcolepsy confirmed by sleep testing, or shift work disorder with documentation of a qualifying work schedule and functional impairment. Off-label requests for cognitive enhancement are unlikely to be approved under a program that covers drugs for FDA-approved indications.

Specific claims about PA turnaround time (for example, a "48 to 72 hour" clearance window) and specific appeal deadlines are the kind of detail that changes with policy updates and should be confirmed directly with New York State Medicaid resources or, for marketplace plans, through NY State of Health, rather than assumed from a fixed number in an article. If you are enrolled in a Medicaid Managed Care plan, the PA process routes through that managed care organization rather than directly through the state, and the documentation requirements can differ by plan.

If a PA request is denied, New York law provides an appeal and fair hearing pathway. The exact filing deadline should be confirmed on the denial notice itself, since stating a specific day count here without a verified source risks giving a reader the wrong deadline.

Commercial Insurance Formulary Placement

Most commercial insurers operating in New York place generic modafinil somewhere on their formulary, usually as a preferred or non-preferred generic, with brand Provigil rarely covered without a formulary exception. Which specific insurer places modafinil on which specific tier, and what the resulting copay is, depends on the individual plan design and changes at renewal. This article does not name specific tier assignments for specific insurers, because those assignments are plan-year-specific and were not independently confirmed for this draft; a wrong tier claim is more harmful than no claim.

Plans purchased through the NY State of Health marketplace are subject to Essential Health Benefit rules, which require coverage of prescription drugs for FDA-approved indications, but formulary tier and copay still vary by carrier and plan. Step therapy (trying a different wakefulness agent first) and quantity limits (commonly 30 tablets per 30 days) are common utilization management tools for controlled substances generally, though whether your specific plan applies them to modafinil should be confirmed with your plan's pharmacy benefit documents.

If coverage is denied, New York members generally have the right to an internal appeal followed by an external review through the New York Department of Financial Services.

Discount Programs and Lower-Cost Channels

Several channels are commonly used to reduce out-of-pocket modafinil costs and are worth asking about, though specific savings percentages and current prices should be checked directly rather than assumed:

• Manufacturer savings cards for brand or generic modafinil, when available, typically exclude patients with government insurance (Medicaid, Medicare, TRICARE). Availability changes over time; check the manufacturer's current patient program directly.
• Third-party discount cards (GoodRx, RxSaver, SingleCare, and similar services) negotiate pharmacy-specific pricing that can beat cash price and sometimes beats an insurance copay, particularly before a deductible is met.
• Mail-order flat-fee pharmacy models, such as Cost Plus Drugs, are commonly cited as a low-cost option for generic modafinil; the current price should be checked on the pharmacy's own site rather than quoted from memory, since flat-fee models still adjust pricing over time.
• Patient assistance programs exist for some Schedule IV medications through manufacturer charitable arms and databases such as NeedyMeds; eligibility is typically income-based and should be confirmed directly with the program.

Verification Checklist: What's Stable vs. What You Must Confirm Today

Use this before you make a decision based on any modafinil cost or coverage claim, whether from this page or elsewhere.

Stable facts you can generally rely on without re-checking (federal/clinical, changes rarely):

• Modafinil's FDA-approved indications are narcolepsy, OSA adjunct therapy, and shift work disorder, confirm on the FDA drug label database if a specific indication matters to your situation.
• Modafinil is a Schedule IV controlled substance federally, which affects refill limits and prescribing rules.
• Generic modafinil has been FDA-approved and commercially available for years, from more than one manufacturer.
• New York permits 503A compounding of controlled substances by licensed pharmacies under Board of Pharmacy oversight, and permits telehealth prescribing of controlled substances under state law.

Date-sensitive facts you must confirm before relying on them (insurer, state agency, or pharmacy-specific, can change monthly or at plan renewal):

• The current cash price of generic modafinil at your specific pharmacy (call or check the pharmacy's own quote; do not rely on a statewide average).
• Whether brand Provigil or generic modafinil is on your plan's formulary this plan year, and at what tier/copay, check your plan's current formulary document or member portal, not last year's figure.
• Your specific New York Medicaid or Medicaid Managed Care plan's current PA documentation requirements and expected turnaround time, confirm with the plan or NY State Medicaid directly.
• The exact appeal or fair hearing deadline stated on your specific denial notice, not a generic day count from an article.
• Whether a manufacturer or third-party discount card currently excludes your insurance type, and its current negotiated price at your pharmacy.
• The current price and shipping terms at any mail-order or flat-fee pharmacy you're considering.
• Whether your prescriber and pharmacy require an audio-video telehealth visit versus allowing audio-only for your specific type of visit (initial vs. refill), per current insurer and state rules.

If a number in this checklist's second column matters to a decision you're making today, treat this article as a starting point for questions to ask, not as the final answer.

Compounded Modafinil in New York: What It Is and When It's Used

A 503A compounding pharmacy prepares a medication for an individual patient based on a specific prescription, as distinct from a 503B outsourcing facility that produces batches without patient-specific orders. In New York, 503A pharmacies compounding modafinil must hold a valid state license and follow USP compounding chapters as enforced by the New York State Board of Pharmacy, and information about compounding oversight generally is also available through federal drug compounding regulatory resources.

Compounding is a narrow-use option. It may be considered when a patient needs a strength not commercially manufactured (for example, a lower dose for titration), has a documented allergy to an inactive ingredient in the commercial generic, or needs a different dosage form. It is not a way around the prescription requirement: compounded modafinil remains a Schedule IV controlled substance subject to the same federal refill limits as the manufactured product. Cost varies by pharmacy and should be quoted directly rather than assumed.

Telehealth Prescribing in New York

New York law permits telehealth prescribing of controlled substances including modafinil, generally requiring a licensed New York prescriber and, for most initial Schedule IV prescriptions, an audio-video encounter rather than audio-only. Prescriptions for controlled substances in New York are transmitted electronically through the state's controlled substance prescription monitoring infrastructure. Because insurer and platform-specific rules about audio-only follow-ups vary and can change, confirm the current requirement with your specific prescriber or plan before assuming a visit format will be accepted.

Consultation fees for telehealth visits (separate from the medication cost itself) vary by platform and visit type; specific dollar ranges for individual telehealth companies were not independently verified for this draft and are not repeated here.

How Modafinil Compares to Other Wakefulness-Promoting Options

Armodafinil (Nuvigil), the R-enantiomer of modafinil, has a longer elimination half-life and is generally considered clinically comparable to modafinil for excessive daytime sleepiness, with the practical difference for most patients coming down to formulary placement and copay rather than a meaningful efficacy gap. Newer agents such as solriamfetol (Sunosi) and pitolisant, both approved for narcolepsy-related excessive sleepiness, are substantially more expensive and have more limited generic availability as of this writing; their list prices are commonly reported to run well above modafinil's generic price, though exact current figures should be confirmed rather than assumed given how quickly specialty drug pricing changes.

What Is Established, What Is Plausible, and What Isn't Established

Established: Modafinil is FDA-approved for narcolepsy, OSA adjunct, and shift work disorder; it is Schedule IV; generic versions exist from multiple manufacturers and are meaningfully cheaper than brand Provigil; New York permits 503A compounding and telehealth prescribing of controlled substances under defined rules; New York Medicaid and most commercial insurers require some form of prior authorization or utilization management for this drug class.

Plausible but not confirmed for this draft: Specific statewide average cash prices, specific insurer tier placements, specific PA turnaround times, and specific compounding-pharmacy price ranges circulate widely in secondary sources but could not be verified against a primary pricing or policy document here.

Not established: Any claim that a fixed dollar figure quoted today will still be accurate at the time you fill a prescription. Pharmacy cash prices, insurer formularies, and Medicaid PA policies are reviewed and revised on their own schedules, independent of this article's publication date.

When to Seek Care Instead of Comparison Shopping

Cost research should never delay evaluation for excessive daytime sleepiness that affects driving safety or job performance. If sleepiness is severe, sudden, or accompanied by other neurological symptoms, that warrants a clinical evaluation rather than a pricing decision, and urgent symptoms (chest pain, severe allergic reaction, fainting) after taking any stimulant-class medication warrant emergency care, not a wait for a cheaper refill.